Login
$AKTX
$7.63 -$0.59 (7.23%) Close

Company Executives

$AKTX Management Team

Mr. Hoyoung Huh

Independent Chairman of the Board

Age 56
Compensation -
Sex Male

Mr. Abizer Gaslightwala

President

Chief Executive Officer

Director

Age 51
Compensation -
Sex Male

Mr. Kameel Farag

Interim Chief Financial Officer

Age 47
Compensation -
Sex Male
Directors
6
serving now
Independent
5 of 5
stated in the proxy; 1 not stated
Average tenure
Not stated
from year joined
CEO also chairs the board
No
Hoyoung Huh
Director Age On board Independent Committees Other public boards 2025 pay Source
Patel
Not stated Not stated Independent None stated None stated Not stated
Bazemore
Not stated Not stated Independent None stated None stated Not stated
Neal
Not stated Not stated Independent None stated None stated Not stated
Hoyoung Huh
Not stated Not stated Independent None stated None stated $549,205
Prudo
Not stated Not stated Independent None stated None stated Not stated
Gaslightwala
Not stated Not stated Not stated None stated None stated Paid as CEO

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

14 disclosed in the 10-K annual report
directors and officers
directors and officers of the Company
$0.4041 per Pre-Funded Warrant and Series G Warrant
December 2025

Unregistered Pre-Funded Warrants and Series G Warrants issued to directors and officers in a concurrent private placement

Mr. Kameel Farag
Interim Chief Financial Officer
Amount not stated
2025

Consulting agreement under which Mr. Farag serves as Interim Chief Financial Officer

With KDF Ventures LLC Open in proxy
directors
directors
Amount not stated
August 2025

August 2025 unsecured promissory notes issued to directors

related parties
recipients of August 2025 Notes
Amount not stated
2025

Extension of expiration date of Series A Warrants held by related parties

Mr. Abizer Gaslightwala
President and Chief Executive Officer
Amount not stated
March 14, 2025

Employment agreement providing base salary, annual cash bonus target and share-based compensation

all directors
directors
Amount not stated
March 2025

Participation in March 2025 private placement of Units

Dr. Hoyoung Huh
Chairman
$1.0 million
March 2025

Purchased Units in March 2025 Offering, paid by cancelling $1.0 million of notes previously issued to him

Dr. Hoyoung Huh
Chairman of the Board
Amount not stated

Notes payable to Dr. Huh assumed in the Peak Bio acquisition (2021 Notes and January 2024 Note)

Dr. Hoyoung Huh
Chairman of the Board
Amount not stated
August 2025

Agreed to purchase an August 2025 Note, paid by cancelling January 2024 Note principal and accrued interest plus cash

Dr. Samir Patel
former Interim President and Chief Executive Officer and director
$50,000 per month
from May 1, 2024

Interim CEO Agreement as independent contractor; compensation later amended to NQSOs

Dr. Ray Prudo and Dr. Samir Patel
Dr. Prudo was Chairman at the time; Dr. Patel was then Interim President and Chief Executive Officer and director
$1.0 million
May 10, 2024

Unsecured convertible promissory notes bearing 15% interest, issued for gross proceeds

The Doctors Laboratory
entity with a common director through May 2025
Less than $0.1 million plus VAT
2025 and 2024

Lease of office space for former U.K. headquarters in London

The Doctors Laboratory
entity with a common director through May 2025
Less than $0.1 million
2025 and 2024

Administrative services provided by TDL through October 2025

entity in which Dr. Huh is a director
entity in which the Chairman, Dr. Huh, is a director
Less than $0.1 million
As of December 31, 2025 and 2024

Amount due to an entity assumed in November 2024, included in accounts payable

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support